SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

10 May 2019 15:08

RNS Number : 7179Y
Forterra plc
10 May 2019
 

10 May 2019

Forterra plc

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 26 April 2019 of share options granted to management under the 2016 Performance Share Plan (PSP), the Company was notified on the 9 and 10 May 2019 that on the 8 and 9 May the following exercise and sale transactions took place:

Stephen Harrison, Shatish Dasani, Ben Guyatt and George Stewart exercised options granted under the PSP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities. In addition, George Stewart also exercised options granted under the Deferred Annual Bonus Plan (DABP) which had vested in 2018. Again, sufficient shares were sold to meet the appropriate tax and national insurance liabilities with the balance being retained.

Name

Status

No. of shares exercised

Sale Date

Number of shares sold

Price

Number of shares retained

Beneficial interest

% of ISC

PSP

DABP

Stephen Harrison

PDMR

204,073

8/5/19

96,252

£2.883

107,821

134,532

< 1%

Ben Guyatt

PDMR

35,712

8/5/19

16,844

£2.883

18,868

24,424

< 1%

George Stewart

PDMR

24,488

17,306

8/5/19

19,713

£2.883

22,081

31,183

< 1%

Shatish Dasani

PDMR

122,443

9/5/19

57,751

£2.825

64,692

177,475

< 1%

The 2016 PSP awards were granted with half of the awards subject to an EPS performance condition and the other half of the awards subject to a TSR performance condition. The EPS performance condition vested at 36.9% of the maximum and the TSR performance condition vested at 100% of the maximum. The Remuneration Committee determined that, in accordance with the rules of the scheme, participants would receive dividend equivalent shares at the rate of 0.073294 additional share for every vesting share. The Remuneration Committee also agreed to waive the 1p per option cost upon exercise.

The shares to be retained by management are to be transferred to management by the Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stephen Harrison

2.

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

204,073 options vesting

 

96,252 shares sold to settle tax and NI

 

107,821 shares acquired

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

96,252

£277,795

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ben Guyatt

2.

Reason for the notification

a)

Position/status

PDMR (Director of Finance and Company Secretary)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

 

 

35,712 options vesting

 

16,844 shares sold to settle tax and NI

 

18,868 shares acquired

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

16,844

£48,561

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

George Stewart

2.

Reason for the notification

a)

Position/status

PDMR (Operations Director)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP on 31 May 2016 and vesting on 26 April 2019 along with options granted under the DABP granted on 1 June 2016 and vesting on 26 April 2018

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

 

41,794 options vesting

 

19,713 shares sold to settle tax and NI

 

22,081 shares acquired

 

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

19,713

£56,833

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Shatish Dasani

2.

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.825

 

 

£Nil

 

122,443 options vesting

 

57,751 shares sold to settle tax and NI

 

64,692 shares acquired

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.825

57,751

£163,147

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGUAUAUPBGCU
Date   Source Headline
11th Jun 20262:52 pmRNSGrant under Long Term Incentive Plan
11th Jun 20267:00 amRNSDirectorate change
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20269:45 amRNSTransaction in Own Shares
2nd Jun 202612:32 pmRNSEmployee Benefit Trust Share Purchase
2nd Jun 202612:30 pmRNSTotal Voting Rights and Capital
1st Jun 20267:00 amRNSAppointment of New Independent NED
27th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:03 pmRNSHolding(s) in Company
19th May 20264:41 pmRNSAnnual General Meeting 2026 Results
19th May 20267:01 amRNSTransaction in Own Shares
19th May 20267:00 amRNSAGM Trading Update
12th May 20261:32 pmRNSTransaction in Own Shares
12th May 20267:00 amRNSAGM RESOLUTION – APPROVAL OF REMUNERATION POLICY
7th May 20261:43 pmRNSHolding(s) in Company
6th May 202610:50 amRNSTransaction in Own Shares
6th May 20269:58 amRNSTotal Voting Rights and Capital
6th May 20269:55 amRNSEmployee Benefit Trust Share Purchase
28th Apr 202610:20 amRNSHolding(s) in Company
28th Apr 202610:18 amRNSTransaction in Own Shares
21st Apr 202611:31 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20265:40 pmRNSNotice of Annual General Meeting 2026
14th Apr 202610:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAppointment of new Independent NED
9th Apr 202610:15 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSDirector Declaration
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20262:07 pmRNSTotal Voting Rights
7th Apr 202612:47 pmRNSEmployee Benefit Trust Share Purchase
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20261:03 pmRNSDirector / PCA Shareholdings
25th Mar 202610:50 amRNSAnnual Report and Accounts 2025
24th Mar 202610:40 amRNSTransaction in Own Shares
24th Mar 20269:01 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSReplacement:Grant under Deferred Annual Bonus Plan
20th Mar 20268:45 amRNSGrant under Deferred Annual Bonus Plan
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 20263:27 pmRNSEmployee Benefit Trust Share Purchase
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.